TEMAZEPAM - AN OVERVIEW

Prevent coadministration with delicate CYP3A substrates. If coadministration unavoidable, keep track of for adverse reactions and decrease CYP3A substrate dose in accordance with solution labeling.Respiratory and cardiovascular position; CBC and urinalysis periodically throughout prolonged use; daytime alertness; conduct profileCoadministration of